Background: Anticonvulsant use has been linked to bone deficits in specific patient populations. We studied the association between anticonvulsant use and bone health in a population-based sample of men and women.
Methods: Data from 1996 people, 926 men (age:24-73y) and 1070 women (21-94y) participating in the Geelong Osteoporosis Study were included. Bone mineral density (BMD, g/cm2) of the PA-spine and total hip was measured using dual-energy X-ray absorptiometry (Lunar). Bone quality was determined using quantitative heel ultrasound (QUS). Anthropometry was conducted and socioeconomic status was determined. Medication and lifestyle information was obtained via questionnaire. Linear regression was used to test associations between anticonvulsant use and bone health before and after adjustment for potential confounders.
Results: Seventeen (1.8%) men and 20 (1.9%) women reported anticonvulsant use. In men, anticonvulsant users had 9.1% lower adjusted mean BMD at the spine and hip compared to non-users. Body mass index (28.5 kg/m2) was an effect modifier at the spine. Anticonvulsant users also had 1.8% lower speed of sound (SOS), 10.6% lower broadband ultrasound attenuation (BUA) and 13.7% lower stiffness index (SI) compared to non-users. No significant association was observed between anticonvulsant use in women and spinal BMD, SOS, BUA or SI but BMD tended to be 5.8% lower at the hip compared to non-users.
Conclusion: Our data suggest that bone quantity and quality, assessed using BMD and QUS, are lower for men and possibly women who use anticonvulsants. While further exploration into potential mechanisms is needed, our findings suggest that monitoring bone health among users of anticonvulsants is warranted.
Loading...
On 28 Jan, 2021
On 12 Jan, 2021
On 12 Jan, 2021
On 12 Jan, 2021
On 01 Jan, 2021
Received 29 Dec, 2020
On 15 Nov, 2020
Invitations sent on 14 Nov, 2020
On 07 Nov, 2020
On 07 Nov, 2020
On 07 Nov, 2020
Posted 05 Aug, 2020
On 20 Sep, 2020
Received 09 Sep, 2020
Received 29 Aug, 2020
On 17 Aug, 2020
Invitations sent on 13 Aug, 2020
On 13 Aug, 2020
On 27 Jul, 2020
On 26 Jul, 2020
On 26 Jul, 2020
On 23 Jul, 2020
On 28 Jan, 2021
On 12 Jan, 2021
On 12 Jan, 2021
On 12 Jan, 2021
On 01 Jan, 2021
Received 29 Dec, 2020
On 15 Nov, 2020
Invitations sent on 14 Nov, 2020
On 07 Nov, 2020
On 07 Nov, 2020
On 07 Nov, 2020
Posted 05 Aug, 2020
On 20 Sep, 2020
Received 09 Sep, 2020
Received 29 Aug, 2020
On 17 Aug, 2020
Invitations sent on 13 Aug, 2020
On 13 Aug, 2020
On 27 Jul, 2020
On 26 Jul, 2020
On 26 Jul, 2020
On 23 Jul, 2020
Background: Anticonvulsant use has been linked to bone deficits in specific patient populations. We studied the association between anticonvulsant use and bone health in a population-based sample of men and women.
Methods: Data from 1996 people, 926 men (age:24-73y) and 1070 women (21-94y) participating in the Geelong Osteoporosis Study were included. Bone mineral density (BMD, g/cm2) of the PA-spine and total hip was measured using dual-energy X-ray absorptiometry (Lunar). Bone quality was determined using quantitative heel ultrasound (QUS). Anthropometry was conducted and socioeconomic status was determined. Medication and lifestyle information was obtained via questionnaire. Linear regression was used to test associations between anticonvulsant use and bone health before and after adjustment for potential confounders.
Results: Seventeen (1.8%) men and 20 (1.9%) women reported anticonvulsant use. In men, anticonvulsant users had 9.1% lower adjusted mean BMD at the spine and hip compared to non-users. Body mass index (28.5 kg/m2) was an effect modifier at the spine. Anticonvulsant users also had 1.8% lower speed of sound (SOS), 10.6% lower broadband ultrasound attenuation (BUA) and 13.7% lower stiffness index (SI) compared to non-users. No significant association was observed between anticonvulsant use in women and spinal BMD, SOS, BUA or SI but BMD tended to be 5.8% lower at the hip compared to non-users.
Conclusion: Our data suggest that bone quantity and quality, assessed using BMD and QUS, are lower for men and possibly women who use anticonvulsants. While further exploration into potential mechanisms is needed, our findings suggest that monitoring bone health among users of anticonvulsants is warranted.
Loading...